Who owns Diamedica Therapeutics Inc?
- Ticker: DMAC
- CUSIP Number: 25253x207
Tip: Access positions for across all investors
Analyze quarterly positions in Diamedica Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Diamedica Therapeutics stock
Who bought or sold Diamedica Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.0M | $2.8M | 26% | Mar 2024 |
|
| Omega Advisors | 884k | $2.4M | 1% | Mar 2024 |
|
| First Manhattan | 850k | $2.4M | 641% | Mar 2024 |
|
| Paragon Associates & Paragon Associates Ii Joint Venture | 500k | $1.4M | 6% | Dec 2023 |
|
| Geode Capital Management | 239k | $663k | 9% | Mar 2024 |
|
| Bleichroeder | 222k | $631k | 0% | Dec 2023 |
|
| Susquehanna International | 209k | $580k | 100% | Mar 2024 |
|
| Northern Trust | 128k | $354k | 42% | Mar 2024 |
|
| Aristides Capital | 106k | $295k | 0% | Mar 2024 |
|
| BlackRock | 103k | $286k | 2% | Mar 2024 |
|
| Morgan Stanley | 92k | $254k | -2% | Mar 2024 |
|
| Catalyst Financial Partners | 36k | $94k | 0% | Mar 2024 |
|
| Citadel Advisors | 31k | $87k | 21% | Mar 2024 |
|
| Bank of New York Mellon | 24k | $67k | -30% | Mar 2024 |
|
| Stonebridge Capital Advisors | 20k | $57k | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 17k | $47k | 0% | Mar 2024 |
|
| Jane Street | 15k | $42k | -36% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 15k | $40k | 4% | Mar 2024 |
|
| Charles Schwab Investment Management | 13k | $37k | 0% | Mar 2024 |
|
| Massmutual Trust | 4.8k | $13k | 0% | Mar 2024 |
|
| Us Bancorp | 4.3k | $12k | 0% | Mar 2024 |
|
| Naples Money Management | 3.0k | $8.2k | -23% | Mar 2024 |
|
| Tower Research Capital | 2.7k | $7.5k | -28% | Mar 2024 |
|
| UBS Group | 1.9k | $5.3k | 100% | Mar 2024 |
|
| TD Waterhouse Canada | 1.1k | $3.9k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 1.0k | $2.8k | 0% | Mar 2024 |
|
| Legend Financial Advisors | 1.0k | $2.8k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 845.00 | $0 | -22% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 230.00 | $637.008000 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 175.00 | $484.995000 | 2% | Mar 2024 |
|
Who sold out of Diamedica Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Altium Capital Management | Sep 2023 | 496k | $1.3M |
| Eudaimonia Asset Management | Sep 2023 | 213k | $548k |
| Millennium Management | Dec 2023 | 29k | $82k |
| H D Vest Advisory Services | Dec 2023 | 13k | $36k |
| Jpmorgan Chase & Co | Dec 2023 | 564.00 | $1.6k |
| Simplex Trading | Dec 2023 | 481.00 | $999.999000 |